INVICTUS ANNOUNCES APPOINTMENT OF NEW CFO
March 15 2019 - 9:14AM
INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company")
(TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce
the appointment of Harbir Toor as Chief Financial Officer (“CFO”)
on March 7, 2019, to succeed Dylan Easterbrook. Ms. Toor
brings to Invictus nearly 20 years of financial management
experience in both public and private companies, including
high-growth and startup stage organizations. Ms. Toor most recently
served as Vice President, Finance of a private, clinical stage
biopharmaceutical company and played a key role in multiple equity
and debt financings, including a US$25 million equity investment.
Prior to that, Ms. Toor held various senior finance positions
including Interim Finance Director of a not-for-profit organization
and Corporate Controller of a public pharmaceutical company. In her
roles, Ms. Toor excelled in strategy execution, shareholder value
creation, and risk management. Ms. Toor began her career with KPMG
performing audit, tax and accounting work for major clients. Ms.
Toor is a Chartered Professional Accountant (CPA, CA) and holds a
Bachelor in Business Administration degree from Simon Fraser
University in Canada.“With Ms. Toor onboard, we have made a strong
addition to our go-forward leadership team. Her experience with
NASDAQ and Toronto Stock Exchange companies will serve Invictus
well as we pursue the next stage of our growth strategy,” said
George E. Kveton, President and CEO of Invictus. “On behalf of the
team at Invictus, I want to thank Dylan for his substantial
contribution and dedication to the Company, and for ensuring a
smooth transition.”
For more information, please visit www.invictus-md.com.
On Behalf of the Board,George E. KvetonChief Executive Officer
and Director
Jessica MartinVice President, Public Relations and Regulatory
Affairs(833) 879-4363
About Invictus
Invictus is a global cannabis company offering a selection of
products under a wide range of brands. Our integrated
route-to-customer approach is defined by five pillars of sales and
distribution including medical, adult-use recreational, retail,
Licensed Producer to Licensed Producer and international.
Invictus has partnered with business leaders to convey our
corporate vision, including KISS music legend and business mogul
Gene Simmons as our Chief Evangelist Officer. To meet growing
demand, Invictus is expanding its cultivation footprint, with three
cannabis production facilities licensed under the Cannabis Act and
Cannabis Regulations in Canada. To accommodate domestic and
international sales, Invictus’ wholly-owned subsidiary, Acreage
Pharms Ltd., is well advanced in building its Phase 3 purpose-built
cultivation facility to be European Union Good Manufacturing
Practices compliant. The Company is targeting for up to 50 percent
of its production to comprise medical cannabis. To ensure
consistency in quality and supply, Invictus participates in all
aspects of the growing process through its subsidiary, Future
Harvest Development Ltd., a high-quality fertilizer and nutrients
manufacturer. Invictus drives sustainable long-term shareholder
value through a diversified product portfolio with over 70 Health
Canada approved strains and a multifaceted distribution strategy
including medical, adult-use, international, Licensed Producer to
Licensed Producer and retail stores. For more information visit
www.invictus-md.com.
Neither the TSX Venture Exchange nor its Regulation Services
Provider accepts responsibility for the adequacy or accuracy of
this release.
Jessica Martin
Invictus
(833) 879-4363
jessica@invictus-md.com
Invictus MD Strategies (TSXV:GENE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Invictus MD Strategies (TSXV:GENE)
Historical Stock Chart
From Apr 2023 to Apr 2024